Indi Molecular's Seed VC - II Round

Indi Molecular raised a round of funding on December 10, 2013. Investors include Asset Management Ventures.

Indi Molecular is an emerging life sciences company that is developing a synthetic class of diagnostic and therapeutic agents with antibody-like properties: protein-catalyzed capture agents. PCCs were…

Articles about Indi Molecular's Seed VC - II Round: